L&S Venture Capital

L&S Venture Capital is a venture capital firm established in 2006 and located in Seoul, South Korea. The firm specializes in incubation, seed, early, and expansion stage investments across various sectors. Its investment focus includes electronic components such as smartphones and telecommunications equipment, as well as the green energy sector, which encompasses solar, wind, and electric vehicle technologies. Additionally, L&S Venture Capital invests in medical devices, artificial intelligence, the Internet of Things, cloud computing, big data, and media content creation and distribution. The firm primarily targets opportunities in South Korea, particularly in the Seoul, Gyeonggi region, and Chungnam province.

Seongjin Joo

Co-Founding Partner and General Partner

Jihae Kim

Managing Director

Dongchan Kim

Managing Director

Past deals in South Korea

AIRS Medical

Venture Round in 2025
AIRS Medical Co., Ltd. is a South Korean company focused on developing and marketing artificial intelligence-based software for magnetic resonance imaging (MRI). The company's flagship product, SwiftMR, enhances MRI images by utilizing advanced algorithms, including parallel imaging and deep learning, to improve scan speed and image quality. This software not only suggests optimal scanning parameters but also reconstructs images without introducing additional artifacts, thus minimizing motion and hardware-related imperfections. In addition to image reconstruction, AIRS Medical provides tools for assessing image quality and visualizing unseen artifacts, ultimately aiming to improve patient outcomes and streamline institutional efficiency in healthcare settings.

Optolane

Venture Round in 2023
Optolane Technologies Inc. is a biotechnology company based in Seongnam, South Korea, founded in 2012. The company specializes in developing portable photo sensor chip-based PCR machines for life science applications. Its diagnostic device offers alternatives for point-of-care testing (POCT) in molecular and immunoassay diagnostics. By integrating optical and thermal control systems, Optolane's semiconductor-based in-vitro diagnostic devices enable real-time and digital PCR, facilitating timely disease diagnosis and enhancing the quality of life for individuals.

Baum

Series A in 2022
Baum, Inc. specializes in electronic design automation (EDA) software and solutions aimed at enhancing the energy efficiency of semiconductor designs for various sectors, including automotive, mobile, networking, and servers. Founded in 2016 and headquartered in Daejeon, South Korea, the company offers tools that support power and thermal management, allowing engineering teams to optimize low-power consumption in their chip designs. Baum's technology is developed by a team of experienced professionals with backgrounds in semiconductor research and development, as well as business development. As a privately held entity, Baum focuses on providing innovative solutions that address the growing demand for energy-efficient semiconductor technologies.

THE PIRATES

Series C in 2022
The Pirates Co., Ltd. specializes in the development and operation of a mobile application that serves both wholesale and retail markets for seafood products. Established in 2018 and headquartered in Seoul, South Korea, the company also operates an aquatic market news platform that delivers information on fresh seafood offerings. This platform connects consumers with suppliers, providing essential insights into the quality of marine products and facilitating informed purchasing decisions. Through its innovative approach, The Pirates aims to enhance the seafood purchasing experience by bridging the gap between consumers and the fish market.

Trost

Series A in 2021
Trost, operated by Humart Company Co., Ltd., specializes in mental healthcare services, offering a range of online counseling options. Founded in 2016 and headquartered in Seoul, South Korea, Trost utilizes a mobile application to facilitate consultations between users and licensed counselors, enabling effective diagnosis and treatment. In addition to counseling, the platform provides various self-analysis tests, including psychological assessments, personality evaluations, and stress-related tests. Through its employee assistance program, Trost aims to enhance mental well-being in both individual and workplace settings.

Lemonex

Series C in 2021
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.

Microsystems

Seed Round in 2020
MICROSYSTEMS is a technology-focused company specializing in microfluidic technologies for the security and autonomous driving sectors. The company has developed Drop Free Glass (DFG), an innovative electronic self-cleaning glass designed for use in automotive and security camera applications. DFG effectively removes contaminants such as rainwater, fog, frost, and dust from its surface through advanced microfluidic technology. MICROSYSTEMS holds over 40 domestic and international patents related to its self-cleaning technology, which has received recognition as New Excellent Technology (NET) and New Excellent Product (NEP) by the South Korean government for its innovation. Additionally, the company has been awarded the Technology Innovation Award at CES, the largest electronics show globally, for four consecutive years, highlighting its commitment to technological advancement in its field.

Wadiz

Series C in 2019
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

Lemonex

Series A in 2018
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, founded in 2013. It specializes in the development and commercialization of biotherapeutics aimed at treating cancers and other challenging diseases. The company focuses on cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex offers innovative drug delivery solutions, including DegradaBALL, which facilitates the delivery of drug candidates into cultured cells and lesions, and PANGO, a technology for the rapid screening of antiviral drugs. Additionally, Lemonex is engaged in advancing biosensor technology, enhancing the effectiveness of drug delivery methods for healthcare professionals.

Wadiz

Series B in 2017
Wadiz is a prominent crowdfunding platform in South Korea that specializes in both product and equity-based crowdfunding. It connects entrepreneurs and startups with potential investors, facilitating the funding of creative projects and innovative businesses. With a user base of 6.6 million members and 10 million monthly visitors, Wadiz has become a significant player in the crowdfunding landscape, managing over 18,000 projects annually and accumulating a transaction value exceeding $1 billion. Recognized as one of Korea's top game-changing brands, the platform enhances the entrepreneurial ecosystem by providing valuable opportunities for businesses to secure funding while allowing investors to engage with emerging companies at an early stage. Wadiz is preparing to go public on the Korean stock market, further solidifying its position in the industry.

iFunFactory

Series A in 2014
iFunFactory is a South Korean company founded in May 2013, specializing in backend solutions for mobile game development and operation. The company offers a range of products designed to streamline the game creation process, including iFunEngine, a mobile game server framework, and iFun Cloud, a game-specific platform-as-a-service (PaaS) solution. Additionally, iFunFactory provides the iFun Map Editor, a tool for designing game environments. By minimizing development overhead, iFunFactory allows game developers to concentrate on content creation and data analysis, enhancing the overall gaming experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.